secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biomea Fusion, Inc. (BMEA)
CIK:        0001840439
Form:       8-K
Filed at:   2026-01-14T23:59:59+00:00
Accession:  0001193125-26-012908
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biomea Fusion holds JPM conference presentation; no material new information disclosed
--------------------------------------------------------------------------------

- Presented at 44th Annual J.P. Morgan Healthcare Conference on Jan 14, 2026; presentation posted to website.
- Filed updated corporate presentation (Ex. 99.2) for investor use; 8-K body contains no specific financial or pipeline updates.
- Forward-looking statements about clinical programs, but no new data, guidance, or milestones announced in filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840439/000119312526012908/0001193125-26-012908-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840439/000119312526012908/d747443d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-012908

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer